-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Madrigal Pharmaceuticals, Raises Price Target to $745

Benzinga·01/20/2026 13:49:31
Listen to the news
Citizens analyst Jonathan Wolleben maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Market Outperform and raises the price target from $527 to $745.